scholarly journals Risk of high-grade serous ovarian cancer associated with pelvic inflammatory disease, parity and breast cancer

2018 ◽  
Vol 55 ◽  
pp. 110-116 ◽  
Author(s):  
Louise M. Stewart ◽  
Katrina Spilsbury ◽  
Susan Jordan ◽  
Colin Stewart ◽  
C. D’Arcy J. Holman ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Ovarian Cancer ◽  
Pelvic Inflammatory Disease ◽  
Inflammatory Disease ◽  
High Grade ◽  
Serous Ovarian Cancer

scholarly journals Cyclin E1 is a shared biomarker of subsets of high grade serous ovarian cancer (HGSOC) and basal like breast cancer (BLBC)

2019 ◽  
Vol 30 ◽  
pp. ix86
Author(s):  
D. Aziz ◽  
C. Lee ◽  
V. Chin ◽  
K. Fernandez ◽  
D. Etemadmoghadam ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Ovarian Cancer ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Cyclin E1 ◽  
Basal Like Breast Cancer

Evaluating the impact of a history of breast cancer on outcomes in women with high-grade serous ovarian cancer

2018 ◽  
Vol 149 ◽  
pp. 212
Author(s):  
J. Gillen ◽  
M. Rowland ◽  
A.Y. Liu ◽  
S. Vesely ◽  
B. Powell ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Ovarian Cancer ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
History Of ◽  
The Impact

Evaluating the impact of a history of breast cancer on chemotherapy toxicities experienced in women with high grade serous ovarian cancer

2019 ◽  
Vol 154 (1) ◽  
pp. e21
Author(s):  
J. Gillen ◽  
M. Enty ◽  
M. Rowland ◽  
J. Dvorak ◽  
K. Ding ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Ovarian Cancer ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
History Of ◽  
The Impact

scholarly journals Invasive bilateral breast cancer and high grade serous ovarian cancer with BRCA1-germline mutation and brainstem metastasis under PARP inhibitors

2019 ◽  
Vol 06 (03) ◽  
pp. 69-75
Author(s):  
Mihaela Marioara Zahari ◽  
Angelica Rita Chiorean ◽  
Maria Magdalena Duma ◽  
Andrei Ungureanu ◽  
Gabriel Kacso
Keyword(s):  
Breast Cancer ◽  
Ovarian Cancer ◽  
Germline Mutation ◽  
Bilateral Breast Cancer ◽  
Parp Inhibitors ◽  
High Grade ◽  
Serous Ovarian Cancer

Phase I study of oral BKM120 and oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 2510-2510 ◽  
Author(s):  
Ursula Matulonis ◽  
Gerburg M. Wulf ◽  
Michael J. Birrer ◽  
Shannon Neville Westin ◽  
Philippa Quy ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Ovarian Cancer ◽  
Phase I ◽  
Triple Negative Breast Cancer ◽  
Phase I Study ◽  
Triple Negative ◽  
High Grade ◽  
Serous Ovarian Cancer
Sign in / Sign up

Export Citation Format

Share Document